Thus, TSPO intensity is increased in Alzheimer’s disease (AD), stroke, and multiple sclerosis (MS), making imaging TSPO ligands an important system for diagnosing neurodegenerative diseases (Venneti et al., 2006; Lavisse et al., 2012). The gene discussed is TSPO; the disease is early-onset autosomal dominant Alzheimer disease.